Search clinical trials for: Modulation of FiO2

Total 10000 results

University of Melbourne

Recruiting

Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

Cerebrovascular Disorders | Central Nervous System Diseases | Ischemic Stroke, Acute | Brain Disorder

Australia, New Zealand
Asociación para Evitar la Ceguera en México

Withdrawn

Effect of Avastin in Juxtafoveal Telangiectasias

Telangiectasis

Mexico
Region Skane

Completed

Effect of Vitamin K in Critically Ill Patients (VITAKOAG)

Coagulopathy, Consumption | Coagulation Factor Deficiency | Vitamin K Deficiency

Sweden
University Hospital, Brest
Bayer

Completed

Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban (ESPER)

Blood Loss After a Total Hip Replacement

France
University of Dundee
British Geriatrics Society

Completed

Vitamin K Status and Markers of Vascular Function in Patients With and Without Postural Hypotension (VITKOH)

Orthostatic Hypotension

United Kingdom
Assiut University

Not yet recruiting

Tranexamic Acid Effect in Pediatric

Tranexamic Acid Effect in Pediatric Polytraumatized Patients
Consorci Sanitari de l'Alt Penedès i Garraf

Recruiting

Heparinization vs Salinization of the Peripheral Venous Catheter

Catheter Complications

Spain
CHU de Reims

Recruiting

Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients (RESTIT)

Renal Insufficiency

France
Ascension Genesys Hospital

Recruiting

Effect of Early Administration of TXA in Adult Hip Fractures

Postoperative Blood Loss

United States
Hospital de Clinicas de Porto Alegre
University of Sao Paulo; Santa Casa de Porto Alegre

Recruiting

The Effects of Tranexamic Acid or Placebo on Perioperative Bleeding in Adults Undergoing Liver Transplantation.

Hemorrhage

Brazil
Laval University
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie...

Recruiting

Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery

Obesity | Cardiopulmonary Bypass

Canada
Hospices Civils de Lyon

Completed

Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA). (ALINEA)

Inflammatory Choroidal Neovascularization

France
Centre Hospitalier Universitaire, Amiens

Active, not recruiting

Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis (Aticks Live)

Inflammatory Response | Deep Vein Thrombosis

France
Dow University of Health Sciences

Completed

Tranexamic Acid in Patients for Caesarian Delivery. (TXA; CD)

Cesarean Section Complications | Postpartum Hemorrhage | Obstetric Anesthesia Problems

Pakistan
Ottawa Hospital Research Institute
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Terminated

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism (WAVe)

Obesity | Cancer | Venous Thromboembolism

Canada
Assaf-Harofeh Medical Center

Completed

Tranexamic Acid Prophylaxis for Heterotopic Ossification in Elbow Fracture-Dislocation Surgery

Elbow Dislocation | Heterotopic Ossification

Israel
University of Nebraska
Regeneron Pharmaceuticals

Completed

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration (DRAW)

Neovascular Macular Degeneration

United States
Shahid Gangalal National Heart Centre

Completed

A Randomized Comparison of Two Doses of Tranexamic Acid in Open-Heart Surgery

Drug Use

Nepal
University Hospital Inselspital, Berne

Completed

Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

Age Related Macular Degeneration

Switzerland
University of North Carolina, Chapel Hill

Withdrawn

Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery

Surgery | Blood Loss | Pituitary Tumor
Xbrane Biopharma AB
Stada Arzneimittel AG

Completed

Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD (XPLORE)

Macular Degeneration

Israel, Spain, Hungary, United States, Slovakia, Lithuania, Bulgaria, Czechia, Estonia, India, Latvia, Poland, Romania, Russian Federation, Ukraine
Boehringer Ingelheim

Completed

Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;

Stroke

China
Fraser Health
Michael Smith Foundation for Health Research; BC Support Unit

Completed

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

Urologic Diseases | Prostate Cancer | Bladder Cancer | Urinary Retention | Patient Satisfaction | Nurse's Role | Hematuria | Nurse Physician Relations

Canada
Gangnam Severance Hospital
Novartis; Inje University; Severance Hospital; Konkuk University

Completed

Cytokeratin 8 Level in Age-related Macular Degeneration

Age-related Macular Degeneration

Korea, Republic of
Justis Ehlers
Genentech, Inc.

Completed

Safety and Efficacy of Ranibizumab for Diabetic Macular Edema (REACT)

Diabetic Macular Edema

United States
The Christ Hospital

Unknown

Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy (HILUTS)

Lower Urinary Tract Symptoms | Postoperative Urinary Tract Infection

United States
Nagoya City University
Novartis

Completed

Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Japan
Novartis Pharmaceuticals

Completed

Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye (TWEYES)

Wet Age Related Macular Degeneration

Italy
Oregon Health and Science University
Genentech, Inc.

Completed

Lucentis (Ranibizumab) for Eales' Disease

Eales' Disease

United States
Ophthalmica Eye Institute

Unknown

Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery

Wet Macular Degeneration | Cataract Extraction

Greece
Shinshu University

Completed

Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema

Diabetic Macula Edema

Japan
Federal University of São Paulo
Novartis

Withdrawn

Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema

Diabetic Macular Edema

Brazil
Marsden Eye Specialists

Completed

To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus (CONTROL)

Diabetic Macular Oedema

Australia
Centre Hospitalier Universitaire de Besancon

Completed

Which Factors Influence the Duration and the Success of Mechanical Thrombectomy During the Acute Phase of Cerebral Infarction? (REPAIR-FC)

Acute Stroke
University of Missouri-Columbia

Completed

Hemostasis in Open Acetabulum and Pelvic Ring Surgery Using Tranexamic Acid (TXA)

Acetabulum Fractures

United States
Assistance Publique - Hôpitaux de Paris

Suspended

Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients (Childbenox)

Cirrhosis

France
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Recurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous Carcinoma | Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation | Endometrioid Stromal Sarcoma

United States
Vista Klinik

Completed

Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Instituto de Olhos de Goiania

Completed

Assessment of Color Vision in Diabetic Patients

Retinopathy, Diabetic

Brazil
Bartłomiej Wódarski

Unknown

Low vs. Very Low Dose of Prophylactic Tranexamic Acid for Bleeding Reduction During Rhinoplasty

Bleeding Reduction

Poland
Novartis Pharmaceuticals

Completed

Ranibizumab "Treat and Extend" in Diabetic Macular Edma (OPTIMAL)

Diabetic Macular Edema

Norway
University of Pittsburgh

Terminated

Tranexamic Acid for Craniofacial Surgery

Bleeding | Craniosynostosis

United States
David M. Brown, M.D.
Genentech, Inc.

Terminated

A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) (SAVE)

Macular Degeneration | Age Related Macular Degeneration | Wet Age-Related Macular Degeneration | Choroidal Neovascular Membrane | Subfoveal Neovascular Age-Related Macular Degeneration

United States
Suzanne C. Cannegieter, MD PhD
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast)

Pulmonary Embolism | Deep Venous Thrombosis

Netherlands
University of Colorado, Denver
Genentech, Inc.

Completed

Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy (NAION)

Nonarteritic Anterior Ischemic Optic Neuropathy

United States
Sanofi

Terminated

Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line

Thrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL)

Hungary
Ruijin Hospital
Ningbo University

Completed

Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma

Diabetic Retinopathy | Glaucoma, Neovascular
Valley Retina Institute

Unknown

Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN (ELYSIAN)

Proliferative Diabetic Retinopathy
ThromboGenics

Completed

A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) (MIVI-II)

Diabetic Macular Edema

Spain, Belgium, United Kingdom, Italy, Netherlands, Germany
John Kitchens, MD

Unknown

Treatment for Presumed Ocular Histoplasmosis (HANDLE)

Ocular Histoplasmosis

United States

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations